TEAMIT RESEARCH SL
Desconocido
ERDERA: EUROPEAN RARE DISEASES RESEARCH ALLIANCE
TEAMIT RESEARCH SL
participó en un
HORIZON EUROPE:
HORIZON-HLTH-2023-DISEASE-07
The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare...
2024-08-20 - 2031-08-31 | Financiado
2024-08-20 - 2031-08-31 | Financiado
UMBRELLA: Unleashing a CoMprehensive Holistic and Patient Centric Stroke Management for a Better Rapid Adva...
"UMBRELLA is a holistic approach to progress, reshape, and benchmark the overall stroke care pathway and set new and improved standards of c...
2024-07-31 - 2029-09-30 | Financiado
2024-07-31 - 2029-09-30 | Financiado
FIBROTARGET: Validation of novel immunotherapeutic targets against fibrosis in inflammatory bowel diseases
TEAMIT RESEARCH SL
participó en un
HORIZON EUROPE:
HORIZON-HLTH-2022-DISEASE-06-two-stage
Fibrostenosis is the driving reason for the persistent need in bowel resections in inflammatory bowel diseases (IBD). Current IBD therapies...
2023-04-24 - 2028-03-31 | Financiado
2023-04-24 - 2028-03-31 | Financiado
REMEDI4ALL: BUILDING A SUSTAINABLE EUROPEAN INNOVATION PLATFORM TO ENHANCE THE REPURPOSING OF MEDICINES FOR ALL
TEAMIT RESEARCH SL
participó en un
HORIZON EUROPE:
HORIZON-HLTH-2021-DISEASE-04
REMEDI4ALL aims to establish Europe's leadership globally in the repurposing of medicines by creating a vibrant community of practice coveri...
2022-05-19 - 2027-08-31 | Financiado
2022-05-19 - 2027-08-31 | Financiado
PROMISE: Preparing for RSV Immunisation and Surveillance in Europe
TEAMIT RESEARCH SL
participó en un
H2020:
H2020-JTI-IMI2-2020-22-single-stage
RSV causes severe disease in the very young and elderly and results in substantial healthcare costs. In the last 4 years, substantial progre...
2021-05-21 - 2024-04-30 | Financiado
2021-05-21 - 2024-04-30 | Financiado
H2O: H2O Health Outcomes Observatory
TEAMIT RESEARCH SL
participó en un
H2020:
H2020-JTI-IMI2-2019-18-two-stage
Patients' outcomes and experience of health care can be improved through the systematic capture and use of information from their perspectiv...
2020-09-30 - 2025-09-30 | Financiado
2020-09-30 - 2025-09-30 | Financiado
PREMIER: Prioritisation and Risk Evaluation of Medicines in the EnviRonment
TEAMIT RESEARCH SL
participó en un
H2020:
H2020-JTI-IMI2-2019-17-two-stage
There are around 1900 active pharmaceutical ingredients (APIs) in use, yet the environmental risks of only a small proportion of these has b...
2020-06-24 - 2026-08-31 | Financiado
2020-06-24 - 2026-08-31 | Financiado
EU-PEARL: EU Patient cEntric clinicAl tRial pLatform
TEAMIT RESEARCH SL
participó en un
H2020:
H2020-JTI-IMI2-2018-15-two-stage
EU-PEARL has the ambition of transforming the current approach of conducting single-compound clinical trials into the use of cross-company I...
2019-11-27 - 2023-04-30 | Financiado
2019-11-27 - 2023-04-30 | Financiado
PARADIGM: Patients Active in Research and Dialogues for an Improved Generation of Medicines Advancing meaning...
TEAMIT RESEARCH SL
participó en un
H2020:
H2020-JTI-IMI2-2016-10-two-stage
PARADIGM will provide a unique framework that enables structured, effective, meaningful, ethical, innovative, and sustainable patient engage...
2018-06-04 - 2020-11-30 | Financiado
2018-06-04 - 2020-11-30 | Financiado
RESCEU: REspiratory Syncytial virus Consortium in EUrope Sofia ref. 116019
TEAMIT RESEARCH SL
participó en un
H2020:
H2020-JTI-IMI2-2015-06-two-stage
RSV causes severe disease and results in substantial healthcare costs in individuals at the extremes of the age spectrum and in high risk gr...
2016-12-14 - 2022-09-30 | Financiado
2016-12-14 - 2022-09-30 | Financiado
* No se disponen de datos de la empresa actual.